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INTRODUCTION
Smooth muscle tumors of uncertain malignant potential 
(STUMP) are a heterogeneous group of neoplasms, from both 
the histological and clinical point of view. The clinical behav-
iour of these neoplasms is also poorly understood. The major-
ity of cases follow a benign clinical course, however a few can 
metastasize as either tumor of low malignant potential or leio-
myosarcomas. Occasionally, certain types of benign leiomyo-
ma can follow a clinical course that supports their malignant 
potential. We describe a case of a benign cellular leiomyoma 
that subsequently behaved as a STUMP. 
CASE REPORT
A 48-year-old woman was referred to the gynecological clinic 
following the diagnosis of a pelvic mass during an opportunis-
tic health check. She was asymptomatic and otherwise fit and 
healthy. In her family history her mother had been diagnosed 
with breast cancer at the age of 46 years. 
Examination revealed an enlarged fibroid uterus to the size 
of a 16-week pregnancy. She underwent total abdominal hy-
ste  rectomy with conservation of the ovaries and tubes. Histo-
logy showed a well-circumscribed smooth muscle tumor (cel-
lular variant) with foci of degeneration (including infarct-type 
necrosis) but no coagulative tumor cell necrosis and only mild 
focal cytological atypia (Fig. 1). The mitotic rate averaged 2 per 
10 high power fields (HPF, Nikon 80i, ×400 magnification).
She presented, 24 years later with shortness of breath and 
abdominal distension. A CT scan of the abdomen and pelvis 
showed large, bilateral complex pelvic masses and a moder-
ate amount of ascites. No other abnormality was detected. A 
CT pulmonary angiogram showed bilateral pulmonary emboli. 
Serum CA-125 level was 1,250 kU/L (normal range, 0 to 35 kU/L).
Case Report
Late presentation of metastatic smooth muscle 
neoplasm of the uterus with low malignant potential
Gioia N. Canciani
1, Nikolaos Burbos
2, Timothy J. Duncan
2, Ray Lonsdale
3, Joaquin J. Nieto
2
1University of East Anglia Medical School, Norwich; Departments of 
2Obstetrics and Gynaecology and 
3Histopathology, Norfolk and 
Norwich University Hospital NHS Foundation Trust, Norwich, UK
Received Mar 27, 2011, Accepted Apr 19, 2011
Correspondence to Nikolaos Burbos
Department of Obstetrics and Gynaecology, Norfolk and Norwich Universi  ty 
Hospital NHS Foundation Trust, Colney Lane, Norwich NR4 7UY, UK. Tel: 44-
7891788834, Fax: 44-1603 287532, E-mail: nikolaos.burbos@nnuh.nhs.uk
pISSN 2005-0380     
eISSN 2005-0399
Copyright © 2012. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License 
(http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and 
reproduction in any medium, provided the original work is properly cited.
www.ejgo.org
A 48-year-old woman underwent total abdominal hysterectomy with conservation of the ovaries and tubes. Histology showed a 
well-circumscribed smooth muscle tumor with foci of degeneration (including infarct-type necrosis) but no coagulative tumor 
cell necrosis and only mild focal cytological atypia. She presented, 24 years later with shortness of breath and abdominal distension 
and underwent bilateral salpingo-oophorectomy, appendectomy, omental biopsy and para-aortic lymph node sam  pling. 
Histology showed bilateral ovarian smooth muscle tumors with no coagulative tumor cell necrosis or significant cellular atypia. 
The cells were mitotically active. The tumors in both ovaries were most likely secondary to the previous uterine smooth muscle 
neoplasm. To our knowledge, this case is the first in the literature to describe a benign cellular leiomyoma that sub  sequently 
behaved as a smooth muscle tumor of uncertain malignant potential, which recurred 24 years after the initial diagnosis.
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She underwent laparotomy where a large volume of ascites 
was drained. A 20 cm, mobile right ovarian mass and a 15 cm 
left ovarian mass attached to pelvic side wall were noted. No 
abnormalities were detected on the peritoneal surfaces, liver, 
spleen and diaphragm. Bilateral salpingo-oophorectomy, appen-
dectomy, omental biopsy and para-aortic lymph node sam  pling 
was performed. Postoperative recovery was uncomplicated. 
Histology showed bilateral ovarian smooth muscle tumors. 
There was no coagulative tumor cell necrosis or significant 
cellular atypia (Fig. 2). The cells were mitotically active, averag-
ing 6 mitoses per 10 HPF, but up to 12 per 10 HPF in the more 
cellular active areas (Nikon 80i, ×400 magnification). Immu-
no  histochemically, the cells showed strong positivity for des-
min with focal staining for CD 10. There was no staining for 
in  hibin, CD 34, CD 117 or calretinin. The appendix, omentum, 
para-aortic lymph nodes and peritoneal washings showed no 
ab  normalities. 
DISCUSSION
Smooth muscle tumors of uncertain malignant potential 
are a heterogeneous group of neoplasms, from both the his-
tological and clinical point of view. Due to the rarity of these 
tumors, the literature on the topic is limited; a consensus on 
their diagnosis, malignant potential, monitoring and treat-
ment has still not been reached [1-5]. 
The diagnosis of these tumors is often challenging, as inter-
pretative difficulties and subjectivity can be encountered 
when analysing any of the three histological features: cellular 
aty  pia, mitotic index and coagulative tumor cell necrosis. 
These three features are called the Stanford criteria and were 
de  veloped by Bell et al. [2].
The clinical behaviour of these neoplasms is also poorly 
understood. The majority of cases follow a benign clinical 
course, however a few can metastasize as either tumor of low 
malig  nant potential or leiomyosarcomas. This seems to hap-
pen regardless of the initial surgical procedure and in differ-
ent locations. Recurrences behave in a low-grade malignant 
fashion, following a disease-free interval and with a prolonged 
survival, even when they recur as leiomyosarcomas. 
In our case, the neoplasms within both ovaries were morpho-
logically similar. They had a nodular architecture and were com  -
posed of bland spindle shaped cells. Scattered mitotic fi  gures 
were present but these were sparse. There were areas of edema 
and hemorrhage but no evidence of coagulative tumor cell 
necrosis. Hemosiderin laden macrophages were present fo  cally 
secondary to hemorrhagic degeneration. The cells showed 
diffuse staining with desmin and H-caldesmon consistent with 
smooth muscle tumors, and were negative for CKIT and DOG1, 
excluding a gastrointestinal stromal tumor.
The tumors in both ovaries were most likely secondary to the 
previous uterine smooth muscle neoplasm. Although a separate 
primary within both ovaries was a possibility, it is highly unusual 
for primary ovarian smooth muscle neoplasms to be bilateral. 
Although there was no definite coagulative tumor cell necrosis 
in the initial tumor, given the subsequent course of events the 
tumor has behaved as very low grade malignancy, even though 
it did not fit the Stanford criteria.
Very few studies have analysed STUMPs with recurrences. 
Different histological classifications (not always using the 
Stanford criteria), diagnostic methods, length of follow-up 
Fig. 1. Cellular smooth muscle tumor with no significant cytological 
atypia (H&E, ×200).
Fig. 2. Ovary showing well-circumscribed nodule of smooth muscle 
tumor (H&E, ×20).Late presentation of metastatic uterine smooth muscle tumor
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and lack of detailed histological information make it difficult 
to compare the findings and draw conclusions. Even though 
all the reported cases of recurrent STUMPs survived (follow-up 
ranging from post-operative status to 157 months following 
the initial diagnosis), most of the results from the literature are 
controversial. There seems to be no consensus as to which 
histological features of STUMPs predict a higher probability of 
recurrence, the location of recurrence (sites reported include 
pelvis, abdomen, liver, lungs, lymph nodes, humerus, retro-
peritoneum and uterus—if hysterectomy not performed), 
time to recurrence (anywhere between 15 months to 9 years) 
and histological type of recurrences (STUMP or leiomyosarco-
ma) [2,4,6-9]. No demographic characteristics (age, ethnicity, 
tobacco use) are predictive of recurrences [4]. A few studies 
have identified immunohistochemical markers as a predictor 
of recurrences. Poorer prognosis is associated with the pres-
ence of p16 and p53 immunohistochemical positivity [1,10]. 
To our knowledge, this case is the first in the literature to des-
cribe a benign cellular leiomyoma that subsequently be  haved 
as a STUMP, which recurred 24 years after the initial diag  nosis. 
As the primary tumor occurred before the publication of the 
Stanford criteria, the diagnosis of necrotic smooth muscle neo-
plasm of low malignant potential was made. Accor  ding to Bell 
and colleagues [2], the initial tumor should have been classi-
fied as a “benign leiomyoma”. Even though the histological 
features do not fit the diagnosis of STUMP, we believe that the 
clinical behaviour of this tumor did, and the original diagnosis 
was both prescient and correct. Its ability to metastasize 24 years 
later and the clinical presentation with bilateral pulmonary 
em  boli, all support the malignant potential of this neoplasm. 
The pulmonary emboli could have been the result of either 
malignancy-induced hypercoagulability or intravascular lung 
metastases; it was not possible to differentiate between the 
two on imaging.
In conclusion, the classification of STUMPs is still controver-
sial and perhaps even some types of “benign leiomyomas” 
should be added to the list. Being able to find markers to pre-
dict the malignant potential of these neoplasms will be highly 
beneficial, in order to reach a consensus on their diagnosis and 
be able to manage them appropriately. Further studies are 
required to increase the validity of the current literature and add 
more knowledge on the subject. Future hope lies in the identifi-
cation of immunohistochemical, molecular and genetic markers 
for the prediction of recurrent potential of STUMPs.
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